Parmax Pharma

quarterly
yearly
ParticularsSep '24Dec '24Mar '25Jun '25Sep '25
Revenue9.406.294.731.952.54
Expenses9.616.705.452.714.62
EBITDA0.310.12-0.67-0.24-1.58
EBIT-0.09-0.28-1.56-0.48-1.84
Profit Before Tax-0.22-0.39-1.79-0.76-2.08
Net Profit-0.22-0.39-1.49-0.76-2.08
Financial Ratios
Operating Profit Margin3.45%1.91%-36.02%-12.37%-62.45%
Net Profit Margin-2.37%-6.21%-8.70%-39.18%-82.21%
Earning Per Share (Diluted)-0.58-1.05-4.00-2.04-5.56
Dividends Per Share0.000.000.000.000.00